Annual Document
Annual Document according German Securities Prospectus Act, s. 10
Fiscal year 2010/2011
Pursuant to section 10 of the German Securities Prospectus Act (WpPG), which entered into force on July 1, 2005, listed companies are obliged to make annually available to the public a document containing information published or made available to the public within the preceding twelve months in order to comply with certain regulations under German corporate and capital market law (“Annual Document”).
Please note that the information contained or referred to in this Annual Document pursuant to section 10 WpPG is not updated and can therefore be out of date. Neither the Annual Document nor the information contained therein or information to which the Annual Document refers to constitute an offer or a request to make an offer to acquire or sell securities.
From April 1, 2010 up to and including March 31, 2011 SYGNIS Pharma AG published or made available to the public the following information pursuant to section 10 para. 1 WpPG:
Financial Reports
-
Jun 29, 2011
: Annual Report 2011
(PDF, 1.3 MB)
-
Aug 12, 2010
: Financial Report Q1 (April 1st - June 30, 2010)
(PDF, 169KB)
-
Nov 11, 2010
: Financial Report Q2 (July 1st - September, 30 2010)
(PDF, 180KB)
-
Feb 14, 2011
: Financial Report Q3 (October 1st - December 31, 2010)
(PDF, 183KB)
Ad Hoc Releases according to § 15 WpHG
Financial Schedule
-
Jun 29, 2010:
Year-end results of FY 2009/2010 and Annual Report
-
Jun 29, 2010:
Press Conference and Analyst Conference
-
Aug 12, 2010:
Publication of the Financial Report for Q1 (01.04. - 30.06.2010)
-
Nov 11, 2010:
Publication of the Financial Report for Q2 (01.07. - 30.09.2010)
-
Nov 30, 2010:
Annual General Meeting for FY 2009/2010
-
Feb 14, 2011:
Publication of the Financial Report for Q3 (01.10. - 31.12.2010)
Preliminary Announcement on the Disclosure of Financial Statements
Annual Shareholder’S Meeting
Reporting
Corporate News
- Press Releases can be found under Press
Director’s Dealings according to section 15a WpHG
- no such transactions reported
Report on voting rights
Should one of the web links listed here not be functioning, we also offer a digital or print edition of the information.
Please contact:
Corporate Communications
Tel.: +49 6221 454 6
Fax: +49 6221 454 777
E-Mail: investors@sygnis.de